Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2026-02-07 @ 1:34 AM
Study NCT ID:
NCT06675032
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-11-05
First Post:
2024-11-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years
Sponsor:
Shanghai Reinovax Biologics Co.,LTD
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pneumococcal Infectious Disease | View |
Keywords: